The Case of the Recurring Fever
An elderly man had symptoms no one could explain – until Amy Berger, MD, PhD, and her team investigated.
University of California San Francisco
Give to UCSFAn elderly man had symptoms no one could explain – until Amy Berger, MD, PhD, and her team investigated.
Leading scientists share some of the tools and strategies that could help us better confront and contain future outbreaks.
Hidden autoimmunity may explain how the coronavirus wreaks such widespread and unpredictable harm.
UCSF researchers wanted to see if simple tweaks, like avoiding nighttime interruptions to promote sleep, nixing certain prescription drugs, and promoting exercise and social engagement, could decrease delirium in hospitalized older adults.
Scientists now have shown that the weakening of an astronaut’s immune system during space travel is likely due in part to abnormal activation of immune cells called T regulator cells.
UCSF researchers have found a way to double doctors’ accuracy in detecting the vast majority of complex fetal heart defects in utero.
Sophie Dumont, winner of the 2021 Byers Award for Basic Science, focuses on finding out how, as well whether therapeutic targets exist to ensure equal – and healthy – division of chromosomes.
UCSF researchers have figured out precisely what receptor tyrosine kinases are, how they form and their role in cancer.
Loneliness and social isolation have been significant problems for the general population during the COVID-19 pandemic, but for cancer patients these issues were particularly acute, likely due to isolation and social distancing, according to a new UCSF study.
Pioneering neural recordings in patients with Parkinson’s disease by UCSF scientists are providing the groundwork for personalized brain stimulation to treat Parkinson’s and other neurological disorders.
A team at UCSF, in collaboration with colleagues at Stanford University, has unearthed the regulatory DNA sequences of our archaic human ancestors in a discovery that sheds light on how we diverged from them 500,000 years ago.
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome.